Corvus Pharmaceuticals, Inc. - 10-K filing on 2017-03-10

Common Stock

12 Months Ended

Dec. 31, 2016

9. Common Stock

As of December 31, 2016, the amended and restated certificate of incorporation authorizes the Company to issue 290 million shares of common stock and 10 million shares of preferred stock.

Each share of common stock is entitled to one vote. Common stockholders are entitled to dividends if and when declared by the board of directors. As of December 31, 2016, no dividends on common stock had been declared.

The Company reserved shares of common stock on an as-converted basis, for issuance as follows:

	December 31, 2016		December 31, 2015		December 31, 2014
Convertible preferred stock		—		14,274,741		8,921,438
Shares available for future option grants		2,475,600		2,559,499		837,547
Outstanding options		2,350,582		784,136		32,320
Unvested restricted common stock (founders and early exercise of stock options)		611,698		924,535		768,706
Shares reserved for employee stock purchase plan		200,000		—		—

Total		5,637,880		18,542,911		10,560,011